Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma
: long-term outcome of the EORTC 20981 phase III randomized intergroup study.
Professor Peter Littlejohns, clinical and public health director at Nice, said: "Using rituximab as a maintenance treatment after initial chemotherapy for follicular non-Hodgkin's lymphoma
could be a valuable treatment option for hundreds of patients because no such maintenance treatment has so far been available at this stage of the disease."
The broker now cut by 57% the price target to DKK152 and said that the poor results from the study with patients with rituximab refractory follicular non-Hodgkin's lymphoma
(NHL) undermine Arzerra's potential to become a blockbuster drug, that is to reach annual sales of over USD1bn.
Genmab A/S (OMX: GEN), Copenhagen, has completed recruitment of patients in the pivotal Phase III study of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular non-Hodgkin's lymphoma
It was in December 2002, the day before Christmas Eve, that Kirsty was diagnosed with low-grade follicular non-Hodgkin's lymphoma